New Zealand propolis soap has no shelf life. Is it genuine?

This kind of imported eye drops will cause patients to use drugs beyond the expiration date, and the drug supervision department ordered them to call-a long time ago, the neomycin sulfate eye drops (trade name: Palibe) produced by Ligenlan Pharmaceutical Company had hidden dangers of causing patients to use drugs beyond the expiration date, and the Wuhan drug supervision department ordered them to call after investigation. I learned that my first case was involved by the drug supervision department. Responsible for enterprises to implement drug summons, 24-month validity period labeling, 25-month validity period labeling may lead to invalid patient use period. A member of Wuhan Drug Administration inspected a pharmaceutical company in Wuhan, and found that the validity period of balibaijiajing sold by the company was approved by the US Food and Drug Administration to be 2. The expiration date of drug packaging is marked as Chao 1 month, batch number e39909 Pali Baijia, and the production date is 200465438+February. The validity period of the product should be 200665438+. 065438+ 10 actually marked the expiration date as: 200665438+February inspection found that there were similar problems in Paliba ***3 batches of products. The Customs of the US Food and Drug Administration in Wuhan is responsible for telling reporters that the expiration date (exp) should be marked like the original foreign drugs that caused the problem. I used to mark the expiration date of drugs until I ignored the details of product packaging and printing, which brought health risks to patients at the end of the month. The first medicine successfully stopped breaking ice in Wuhan. On May 8, 2006, a pharmaceutical company in Wuhan, the Inspection Bureau of the US Food and Drug Administration in Wuhan, reached a notice of ordering to call drugs, saying that the validity period of three batches of neomycin sulfate eye drops operated by the company was consistent with the national standard, which led to the hidden danger of consumers using drugs beyond the validity period, and ordered the company to be called by Wuhan news media. This medicine was recalled within 30 days. June 65438+May 2006, a pharmaceutical company in Wuhan issued a drug collection announcement. The announcement of my first drug call showed that patients who bought three batches of drugs should use the products before the end of the corresponding validity period, and the packaging should be complete. The company accepted the problem drug and called it public drug safety. The US Food and Drug Administration in Wuhan recently called three batches of drugs for patients, which should be safe because it has not expired. Batch number drugs can still be used by patients beyond the validity period, which is responsible for explaining the urgent need for supervision by the drug supervision department and implementing the compulsory drug recall system. Regulators have previously investigated the market problems of drugs and thoroughly collected them into the hands of society and patients. Drugs can be made well or published. In the early 1970s, it was unnecessary to introduce drug supervision according to the summons system. At present, the United States, Canada, Australia, the European Union, Japan, South Korea and other regions have established relevant compulsory summons systems for illegal drugs. Since June 1, 2006, Wuhan has implemented the Interim Provisions on Summoning Illegal Drugs within a Time Limit, taking the lead in popularizing the compulsory summoning system for illegal drugs. Illegal drugs that diaspora can harm consumers. According to the principle that whoever produces is responsible and the first battalion is responsible, the Food and Drug Administration is responsible for forcibly summoning illegal drugs, which will promote the production enterprises to cut off and strengthen the original drugs. The general public may benefit from the management of the procurement and production process of auxiliary materials, urging pharmaceutical enterprises and medical institutions to standardize the purchase channels, strengthening the management of purchase quality and storage, paying attention to the progress of quality notification of drug supervision departments, and establishing and improving the quality management system (Reporter Fu Mei)